ArticleScientific reports2026
In silico pipeline for GSK 3β inhibitor discovery in Alzheimer's disease using pharmacophore screening, docking, ADME filtering, and MD validation.
Mahmoud S Elkotamy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.